| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation
|
Mizukami, Takuo
|
|
2008
|
26 |
18 |
p. 2270-2283
14 p.
|
artikel
|
| 2 |
Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings
|
Manissero, Davide
|
|
2008
|
26 |
18 |
p. 2253-2259
7 p.
|
artikel
|
| 3 |
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
|
Gatchalian, Salvacion
|
|
2008
|
26 |
18 |
p. 2234-2241
8 p.
|
artikel
|
| 4 |
Despite Leishvaccine and Leishmune® trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis
|
Araújo, Márcio Sobreira Silva
|
|
2008
|
26 |
18 |
p. 2211-2224
14 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2008
|
26 |
18 |
p. CO2-
1 p.
|
artikel
|
| 6 |
Erratum to “Improving global monitoring of vaccine safety: A quantitative analysis of adverse event reports in the WHO Adverse Reactions Database” [Vaccine 2008;26(9):1185–94]
|
Letourneau, Megan
|
|
2008
|
26 |
18 |
p. 2302-2303
2 p.
|
artikel
|
| 7 |
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial
|
Jiang, Wei-Ping
|
|
2008
|
26 |
18 |
p. 2297-2301
5 p.
|
artikel
|
| 8 |
Informing adolescents about human papillomavirus vaccination: What will parents allow?
|
Vallely, Lorraine A.
|
|
2008
|
26 |
18 |
p. 2203-2210
8 p.
|
artikel
|
| 9 |
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Kester, Kent E.
|
|
2008
|
26 |
18 |
p. 2191-2202
12 p.
|
artikel
|
| 10 |
Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases
|
Bardotti, Angela
|
|
2008
|
26 |
18 |
p. 2284-2296
13 p.
|
artikel
|
| 11 |
Pox, patient, and plaque
|
Murphy, Joseph G.
|
|
2008
|
26 |
18 |
p. 2175-2176
2 p.
|
artikel
|
| 12 |
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response
|
Ilyinskii, P.O.
|
|
2008
|
26 |
18 |
p. 2177-2185
9 p.
|
artikel
|
| 13 |
Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants
|
Li, Rong Cheng
|
|
2008
|
26 |
18 |
p. 2260-2269
10 p.
|
artikel
|
| 14 |
Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNγ T cell responses in the dog
|
Goubier, A.
|
|
2008
|
26 |
18 |
p. 2186-2190
5 p.
|
artikel
|
| 15 |
Surface modified liposomes for nasal delivery of DNA vaccine
|
Khatri, Kapil
|
|
2008
|
26 |
18 |
p. 2225-2233
9 p.
|
artikel
|
| 16 |
Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants
|
Schmitt, Heinz-J.
|
|
2008
|
26 |
18 |
p. 2242-2252
11 p.
|
artikel
|
Tijdschrift beschrijving